Comments from the American Academy of Pain MedicineThe American Academy of Pain Medicine thanks the Agency for the opportunity to comment on The Evidence-based Practice Center Program at the Agency for Healthcare Research and Quality [...]
Pain management experts and patient advocates met this past week to begin developing clear evidence-informed guidance for healthcare clinicians on the reduction or elimination of opioids, when appropriate, for those who are prescribed them chronically. National concerns [...]
The U.S. Food and Drug Administration (FDA) has received reports of serious harm in patients who are physically dependent on opioid pain medicines suddenly having these medicines discontinued or the dose rapidly decreased. These include [...]
2019 Commercially Supported Symposia The following Commercially Supported Symposia (CSS) held during the AAPM 35th Annual Meeting & Preconferences March 7-9, 2019 offered meeting attendees an opportunity to expand their pain management knowledge and gain [...]
Guidelines for Expert Witness Qualifications and Testimony A statement by the American Academy of Pain Medicine Preamble The integrity of the litigation process in the United States depends in part on the honest, unbiased, responsible [...]
AAPM is pleased to announce its 2019-2020 Board of Directors, who assumed office on Saturday, March 9, 2019.Learn more about the AAPM Board of Directors, led by President Tim J. Lamer, MD.
Periodically AAPM is asked to provide names of possible research sites for industry-sponsored trials. If you are an AAPM member who is interested in being listed as a potential Principal Investigator and/or as a potential site [...]
Position on Research into the Use of Cannabinoids for Medical Purposes A Position Statement from the American Academy of Pain Medicine The American Academy of Pain Medicine (AAPM) supports regulatory rescheduling of cannabinoids from Schedule [...]
The Evidence Against Methadone as a “Preferred” Analgesic A Position Statement from the American Academy of Pain Medicine The use of methadone as an analgesic for severe chronic pain has expanded in recent years. It [...]
Minimum Insurance Benefits for Patients with Chronic Pain A Position Statement from the American Academy of Pain Medicine Executive Summary The Institute of Medicine (IOM) has documented a public health crisis of chronic pain in [...]
© American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources | Powered by Insight Marketing Group
American Academy of Pain (AAMP) is a nonprofit, 501(c)(6) tax-exempt organization.
